药 物 回 收
|
| |
| Canada: Recall: ERYTHROMYCIN OPHTHALMIC OINTMENT USP: Product sterility may be compromised (English only) |
| |
Health Canada announces that Steri-Med Pharma Inc. is recalling 2 lots of Erythromycin Opthalmic Ointment USP (lot number: 2024E06, 2024E09) from retailers because the sterility of the product may be compromised in the affected lots.
The product is indicated for the treatment of superficial ocular infections involving the conjunctiva and/or cornea caused by organisms susceptible to erythromycin and for the prophylaxis of ophthalmic neonatorum due to N. gonorrhoeae or C. trachomatis.
Please refer to the following website in Health Canada for details:
http://recalls-rappels.canada.ca/en/alert-recall/erythromycin-ophthalmic-ointment-usp-product-sterility-may-be-compromised
In Hong Kong, the above product is not a registered pharmaceutical product. Related news was previously issued by Health Canada, and was posted on the Drug Office website on 2 Dec 2025.
Ends/Wednesday, Dec 24, 2025
Issued at HKT 15:00
|
| |
|
